Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Hepatitis

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 270 articles: HTML format Text format

Single Articles

May 2012
1. SI-TAYEB K , Duclos-Vallee JC, Petit MA
   Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personal.
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   April 2012
2. OO YH , Adams DH
   Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment?
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
3. XU J , Ding T, He Q, Yu XJ, et al
   An In Situ Molecular Signature to Predict Early Recurrence in Hepatitis B Virus-related Hepatocellular Carcinoma.
   J Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. GROESSL EJ , Liu L, Ho SB, Kanwal F, et al
   National patterns and predictors of liver biopsy use for managing hepatitis C.
   J Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. DEUFFIC-BURBAN S , Castel H, Wiegand J, Manns MP, et al
   Immediate versus delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis.
   J Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. ROELANDT P , Obeid S, Paeshuyse J, Vanhove J, et al
   Human pluripotent stem cell derived hepatocytes support complete replication of hepatitis C virus.
   J Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. FELD JJ
   Interferon responses and spontaneous HCV clearance: Is it all a matter of fat?
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
8. CECIL B
   Reply to "Gaps in the achievement of effectiveness of HCV treatment in national VA practice"
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
9. PELLICELLI AM , Romano M, Guarascio P, Vignally P, et al
   Which is the real efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in HCV infected patients with advanced fibrosis ?
   J Hepatol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
10. PENG CY , Chien RN, Liaw YF
    Hepatitis B Virus-Related Decompensated Liver Disease: Benefits of Antiviral Therapy.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2012
11. ASSELAH T
    A revolution in HCV treatment with direct-acting antivirals: from non response to eradication.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
12. PAPATHEODORIDIS GV , Manolakopoulos S, Liaw YF, Lok A, et al
    Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. EUROPEAN ASSOCIATION FOR THE S
    EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
14. JO J , Bengsch B, Seigel B, Rau SJ, et al
    Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. HOPKINS S , Dimassimo B, Rusnak P, Heuman D, et al
    The Cyclophilin Inhibitor SCY-635 Suppresses Viral Replication and Induces Endogenous Interferons in Patients With Chronic HCV Genotype 1 Infection.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. PEISELER M , Sebode M, Franke B, Wortmann F, et al
    FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. LACEK K , Vercauteren K, Grzyb K, Naddeo M, et al
    Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. COSCONEA S , Fontaine H, Meritet JF, Corouge M, et al
    Benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. SHERIDAN DA , Bridge SH, Felmlee DJ, Crossey MM, et al
    Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. SHOUVAL D
    Focus: Long-term treatment with lamivudine in HBeAg negative patients with chronic hepatitis B: To switch or not to switch?
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
21. THOMPSON AJ , Clark PJ, Muir AJ, Sulkowski MS, et al
    Reply to "IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?".
    J Hepatol. 2012;56:742-3.
    PubMed     Text format     Related articles   
    
    
    
    
22. ORLENT H , de Knegt RJ, Janssen HL
    IL28B polymorphism and hepatitis C: A genetic marker of peginterferon-alpha sensitivity devoid from classical interferon-alpha side effects?
    J Hepatol. 2012;56:741-2.
    PubMed     Text format     Related articles   
    
    
    
    
23. MURA VL , Persico M
    HCV infection, HOMA index and sustained virologial response: the step we need to take before moving forward.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
24. DELTENRE P , Mathurin P, Serfaty L
    Reply to Dr. V. La Mura's letter entitled: "HCV infection, HOMA index and sustained virological response: the step we need to take before moving forward"
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
25. LUPBERGER J , Felmlee DJ, Baumert TF
    Cholesterol uptake and hepatitis C virus entry.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
26. MOOKERJEE RP , Jalan R
    Liver Biopsy is Necessary in Alcoholic Hepatitis.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
27. FASANO M , Lampertico P, Marzano A, Di Marco V, et al
    HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. MORENO C , Berg T, Tanwandee T, Thongsawat S, et al
    Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2 to 6: TMC435-C202, a phase IIa, open-label study.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HARFOUCH S , Guiguet M, Valantin MA, Samri A, et al
    Lack of TGFbeta Production by Hepatitis C Virus-Specific T Cells during HCV Acute Phase is Associated with HCV Clearance in HIV co-infection.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. PENNA A , Laccabue D, Libri I, Giuberti T, et al
    Peginteferon-alpha does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. RAMON VC , Antonio LV, Rebeca AA, Antonio MG, et al
    A Predictive Model of Treatment Outcome in Patients with Chronic HCV Infection Using IL-28B and PD-1 Genotyping.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. BERENGUER M , Aguilera V, Rubin A, Ortiz C, et al
    Comparison of two non-contemporaneous HCV-liver transplant cohorts: strategies to improve the efficacy of antiviral therapy.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LAWITZ EJ , Gruener D, Hill JM, Marbury T, et al
    A Phase 1, Randomized, Placebo-Controlled, Three-Day, Dose-Ranging Study of GS-5885, an NS5A Inhibitor, in Patients with Genotype 1 Hepatitis C.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MARCELLIN P , Reau N, Ferenci P, Hadziyannis S, et al
    Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BILLIOUD G , Pichoud C, Parent R, Zoulim F, et al
    Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. FORREST EH , Gleeson D
    Is a Liver Biopsy Necessary in Alcoholic Hepatitis?
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    January 2012
37. DONATO MF , Galmozzi E, Rigamonti C, Aghemo A, et al
    Post-liver transplantantion graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
38. BURROUGHS AK
    Liver transplantation for severe alcoholic hepatitis saves lives.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
39. VILLANUEVA A , Forns X, Llovet JM
    Molecular epidemiology in HCV-related hepatocellular carcinoma: first steps.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. THU THUY PT , Bunchorntavakul C, Tan Dat H, Rajender Reddy K, et al
    A Randomized Trial of 48 versus 24 Weeks of Combination Pegylated Interferon and Ribavirin Therapy in Genotype 6 Chronic Hepatitis C.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. PISCHKE S , Gosling J, Engelmann I, Schlue J, et al
    High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. GUEDJ J , Dahari H, Pohl RT, Ferenci P, et al
    Understanding silibinin's modes of action against HCV using viral kinetic modeling.
    J Hepatol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. VALENTI L , Aghemo A, Stattermayer AF
    Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
44. TREPO E , Pradat P, McCarthy J, Tillmann HL, et al
    Reply to: "Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients"
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
45. LAU GK , Wang FS
    Uncover the immune biomarkers underlying hepatitis B e antigen (HBeAg) seroconversion - a need for more translational study.
    J Hepatol. 2012.
    PubMed     Text format     Related articles   
    
    
    
    
46. SARRAZIN C , Hezode C, Zeuzem S, Pawlotsky JM, et al
    Antiviral strategies in hepatitis C virus infection.
    J Hepatol. 2012;56 Suppl:S88-S100.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. BUGIANESI E , Salamone F, Negro F
    The interaction of metabolic factors with HCV infection: Does it matter?
    J Hepatol. 2012;56 Suppl:S56-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. MATHURIN P , Lucey MR
    Management of alcoholic hepatitis.
    J Hepatol. 2012;56 Suppl:S39-45.
    PubMed     Text format     Related articles   
    
    
    
    
49. ZOULIM F , Locarnini S
    Management of treatment failure in chronic hepatitis B.
    J Hepatol. 2012;56 Suppl:S112-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
50. WILSON GK , Brimacombe CL, Rowe IA, Reynolds GM, et al
    A dual role for hypoxia inducible factor-1alpha in the hepatitis C virus lifecycle and hepatoma migration.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. NIE H , Evans AA, Thomas London W, Block TM, et al
    Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. SALMON D , Bani-Sadr F, Loko MA, Stitou H, et al
    Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-coinfected patients: Results from ANRS CO13 HEPAVIH.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. ROCCO A , de Nucci G, Valente G, Compare D, et al
    (13)C-Aminopyrine Breath Test Accurately Predicts Long-Term Outcome of Chronic Hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. NEUKAM K , Camacho A, Lopez-Biedma A, Rallon N, et al
    Prediction of response to pegylated interferon plus ribavirin in HIV/ hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations and HCV-RNA load.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BES M , Vargas V, Piron M, Casamitjana N, et al
    T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. MA SW , Huang X, Li YY, Tang LB, et al
    High Serum IL-21 Levels after 12 Weeks of Antiviral Therapy Predict HBeAg Seroconversion in Chronic Hepatitis B.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. NISCHALKE HD , Berger C, Luda C, Muller T, et al
    The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian Patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. STICKEL F , Trepo E, Moreno C, Hampe J, et al
    Reply to: "Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C".
    J Hepatol. 2011;55:1471-2.
    PubMed     Text format     Related articles   
    
    
    
    
59. VALENTI L , Colombo M, Fargion S
    Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C.
    J Hepatol. 2011;55:1470-1.
    PubMed     Text format     Related articles   
    
    
    
    November 2011
60. GERMANIDIS G , Hytiroglou P, Zakalka M, Settas L, et al
    Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
61. FORTON DM
    Hepatitis C treatment - Clearing the mind.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
62. RIDRUEJO E , Adrover R, Mando OG, Silva MO, et al
    Entecavir in the Treatment of Chronic Hepatitis B in Kidney Transplantation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
63. TILG H , Moschen AR
    IL-1 cytokine family members and NAFLD: neglected in metabolic liver inflammation.
    J Hepatol. 2011;55:960-2.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
64. PETERSEN J , Ratziu V, Buti M, Janssen HL, et al
    Entecavir Plus Tenofovir Combination as Rescue Therapy in Pretreated Chronic Hepatitis B Patients. An International Multicenter Cohort Study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. HOWELL CD , Gorden A, Ryan KA, Thompson AJ, et al
    Single Nucleotide Polymorphism Upstream of Interleukin 28B Associated with Phase 1 and Phase 2 of Early Viral Kinetics in Patients Infected with HCV Genotype 1.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. LOGGI E , Micco L, Ercolani G, Cucchetti A, et al
    Liver Transplantation from Hepatitis B Surface Antigen Positive Donors: A Safe Way to Expand the Donor Pool.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. NIEDERHAUSER C , Candotti D, Weingand T, Maier A, et al
    Reverse vertical transmission of Hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. BYRNES V , Miller A, Lowry D, Hill E, et al
    Effects of Anti-Viral Therapy and HCV Clearance on Cerebral Metabolism and Cognition.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. WONG VW , Wong GL, Chu WC, Chim AM, et al
    Hepatitis B virus infection and fatty liver in the general population.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. KUROSAKI M , Hiramatsu N, Sakamoto M, Suzuki Y, et al
    Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. SOGA T , Sugimoto M, Honma M, Mori M, et al
    Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
    J Hepatol. 2011;55:896-905.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
72. SAMONAKIS DN , Germani G, Burroughs AK
    Immunosuppression and HCV Recurrence after Liver Transplantation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. HOSHIDA Y , Fuchs BC, Tanabe KK
    Genomic risk of hepatitis C-related hepatocellular carcinoma.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. ASSELAH T , De Muynck S, Broet P, Masliah-Planchon J, et al
    IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. NAHON P , Sutton A, Rufat P, Charnaux N, et al
    A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. SETO WK , Lai CL, Fung J, Wong DK, et al
    Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome.
    J Hepatol. 2011;55:522-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
77. POYNARD T , de Ledinghen V, Zarski JP, Stanciu C, et al
    Relative performances of FibroTest, Fibroscan and biopsy for assessing the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. PATRIZIA CARRIERI M , Cohen J, Salmon-Ceron D, Winnock M, et al
    Coffee consumption and reduced self-reported side-effects in HIV-HCV co-infected patients during PEG-IFN and Ribavirin treatment: results from ANRS CO13 HEPAVIH.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
79. ZHAO H , Lin W, Kumthip K, Cheng D, et al
    A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. CACOUB P , Bourliere M, Lubbe J, Dupin N, et al
    Dermatological side effects of hepatitis c and its treatment: Patient management in the era of direct-acting antivirals.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. ASSELAH T
    Realize the advance in HCV treatment, but remain cautious.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. JOUAN L , Chatel-Chaix L, Melancon P, Rodrigue-Gervais IG, et al
    Targeted impairment of innate antiviral responses in liver of chronic Hepatitis C patients.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. LEE SA , Kim KJ, Kim H, Kim BJ, et al
    Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. KUMADA H , Toyota J, Okanoue T, Chayama K, et al
    Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. DUARTE-ROJO A , Heathcote EJ, Feld JJ
    'Easy to treat' genotypes were not created equal: can rapid virological response (RVR) level the playing field?
    J Hepatol. 2011;55:466-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
86. DANDRI M , Petersen J
    Chimeric Mouse Model of Hepatitis B Virus infection.
    J Hepatol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
87. SCHLOSSER B , Stein A, Neuhaus R, Pahl S, et al
    Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. JILG N , Chung RT
    Adding to the Toolbox: Receptor Tyrosine Kinases as Potential Targets in the Treatment of Hepatitis C.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. AGHEMO A , Colombo M
    Peginterferon Maintenance Therapy in Patients with Advanced Hepatitis C to Prevent Hepatocellular Carcinoma: The Plot Thickens.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. INGILIZ P , Valantin MA, Petrosi P, Finzi L, et al
    Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. ZARSKI JP , Sturm N, Guechot J, Paris A, et al
    Comparison of 9 blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. KAWAHARA T , Asthana S, Kneteman NM
    M-TOR Inhibitors: What Role in Liver Transplantation?
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. MEDERACKE I , Filmann N, Yurdaydin C, Bremer B, et al
    Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis Delta antigen persistence after liver transplantation.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. KRAMER JR , Kanwal F, Richardson P, Mei M, et al
    Gaps in the Achievement of Effectiveness of HCV Treatment in National VA Practice.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. LAN CL , Guillygomarc'h A, Danielou H, Dreau GL, et al
    A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. PRATI GM , Aghemo A, Rumi MG, D'Ambrosio R, et al
    Hyporesponsiveness to pegifnalpha2b plus ribavirin in patients with hepatitis C-related advanced fibrosis.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. FRIEDMAN SL
    Focus.
    J Hepatol. 2011;55:1-2.
    PubMed     Text format     Related articles   
    
    
    
    
98. MUNTEANU M , Ratziu V, Poynard T
    FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted.
    J Hepatol. 2011;55:233.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
99. ESTRABAUD E , De Muynck S, Asselah T
    Activation of Unfolded Protein Response and autophagy during HCV infection modulates innate immune response.
    J Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. ASSELAH T
     A sprint to increase response to HCV treatment: expectancies but caution.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. SHIMADA M , Yoshida S, Masuzaki R, Schuppan D, et al
     Pitavastatin enhances antiviral efficacy of standard pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot study.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
102. CHAN HL , Thompson A, Martinot-Peignoux M, Piratvisuth T, et al
     Hepatitis B surface antigen Quantification: Why and How to use it in 2011 - A Core Group Report.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. BASSENDINE MF , Sheridan DA, Felmlee DJ, Bridge SH, et al
     HCV and the hepatic lipid pathway as a potential treatment target.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
104. SHOUVAL D
     Focus.
     J Hepatol. 2011;54:1085-6.
     PubMed     Text format     Related articles   
     
     
     
     
105. ABE H , Hayes CN, Ochi H, Maekawa T, et al
     IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.
     J Hepatol. 2011;54:1094-101.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2011
106. THOMPSON AJ , Clark PJ, Singh A, Ge D, et al
     Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. DELANG L , Vliegen I, Leyssen P, Neyts J, et al
     In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitors.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. HEZODE C
     Oral combination therapy: Future hepatitis C virus treatment?
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. MISHRA N , Arankalle VA
     Association of polymorphisms in the promoter regions of TNF-alpha (-308) with susceptibility to hepatitis E virus and TNF-alpha (-1031) and IFN-gamma (+874) genes with clinical outcome of hepatitis E infection in India.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. MAUSS S , Berger F, Filmann N, Hueppe D, et al
     Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. HUANG CF , Huang JF, Yang JF, Hsieh MY, et al
     Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. VOLAREVIC V , Mitrovic M, Milovanovic M, Zelen I, et al
     Protective Role of IL-33/ST2 Axis in Con A-Induced Hepatitis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. ROBINET E , Baumert TF
     A first step towards a mouse model for hepatitis C virus infection containing a human immune system.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. JAFFERBHOY H , Miller MH, El Wahed Z, Dillon JF, et al
     Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
115. KUROSAKI M , Izumi N
     Reply to: "Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR"
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
116. HILLERET MN , Larrat S, Stanke-Labesque F, Leroy V, et al
     Does adherence to hepatitis B antiviral treatment correlate with virological response and risk of breakthrough?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     April 2011
117. MOLDOVAN B , Mentha G, Majno P, Berney T, et al
     Demographics and outcomes of severe Herpes simplex virus hepatitis: a registry-based study.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. GAMBARIN-GELWAN M , Jacobson IM
     Chronic hepatitis C genotype 2 and 3: Are we ready for personalized medicine?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
119. HAN GR , Cao MK, Zhao W, Jiang HX, et al
     A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. TILLMANN HL , Patel K, Muir AJ, Guy CD, et al
     Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. FOX AN , Terrault NA
     Individualizing hepatitis B infection prophylaxis in liver transplant recipients.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
122. URBANUS AT , van de Laar TJ, van den Hoek A, Zuure FR, et al
     Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. DELTENRE P , Louvet A, Lemoine M, Mourad A, et al
     Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. SHOUVAL D
     Focus.
     J Hepatol. 2011;54:597-8.
     PubMed     Text format     Related articles   
     
     
     
     
125. BEGRICHE K , Massart J, Robin MA, Borgne-Sanchez A, et al
     Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
     J Hepatol. 2011;54:773-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. MALHI H , Kaufman RJ
     Endoplasmic reticulum stress in liver disease.
     J Hepatol. 2011;54:795-809.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2011
127. LANGE CM , Zeuzem S
     IL28B single nucleotide polymorphisms in the treatment of hepatitis C.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. WEILER-NORMANN C , Schramm C
     Drug induced liver injury and its relationship to autoimmune hepatitis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
129. LUCIFORA J , Arzberger S, Durantel D, Belloni L, et al
     Hepatitis B Virus X protein is essential to initiate and maintain virus replication after infection.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. LOHSE AW
     Rolls Royce for everybody? Diagnosing liver disease by mini-laparoscopy.
     J Hepatol. 2011;54:584-5.
     PubMed     Text format     Related articles   
     
     
     
     
131. THOMPSON MD , Dar MJ, Monga SP
     Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of beta-catenin.
     J Hepatol. 2011;54:506-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2011
132. CRAXI A
     EASL Clinical Practice Guidelines: Management of hepatitis C virus infection.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
133. BOCHUD PY , Bibert S, Negro F, Haagmans B, et al
     IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. DELTENRE P , Corouge M, Canva V, Castel H, et al
     Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. GANE EJ , Rouzier R, Stedman C, Wiercinska-Drapalo A, et al
     Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN alpha-2a/RBV in hepatitis C patients.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. GOLDWASSER J , Cohen PY, Lin W, Kitsberg D, et al
     Naringenin Inhibits the Assembly and Long-Term Production of Infectious Hepatitis C Virus Particles Through a PPAR-Mediated Mechanism.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. BRUYAND M , Dabis F, Vandenhende MA, Lazaro E, et al
     HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. RAJ A , McCall J, Gane E
     "Validation of the "Metroticket" predictor in a cohort of patients transplanted for predominantly HBV-related Hepatocellular Carcinoma"
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. KAMARI Y , Shaish A, Vax E, Shemesh S, et al
     Lack of Interleukin-1alpha or Interleukin-1beta Inhibits Transformation of Steatosis to Steatohepatitis and Liver Fibrosis in Hypercholesterolemic Mice.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. LANGE CM , Bojunga J, Badenhoop K, Zeuzem S, et al
     Reply to the letter to the Editor of Bitetto et al. (JHEPAT-D-11-00152), entitled "vitamin D deficiency and HCV chronic infection: what comes first?"
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
141. BITETTO D , Fabris C, Falleti E, Toniutto P, et al
     Vitamin D deficiency and HCV chronic infection: what comes first?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
142. EL-MAOUCHE D , Mehta SH, Sutcliffe C, Higgins Y, et al
     Controlled HIV Viral Replication, Not Liver Disease Severity Associated with Low Bone Mineral Density in HIV/HCV Co-Infection.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. LUCENA MI , Kaplowitz N, Hallal H, Castiella A, et al
     Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry. The dilemma of the relationship to autoimmune hepatitis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. JAY C , Skaro A, Ladner D, Wang E, et al
     A Comprehensive Risk Assessment of Mortality Following Donation after Cardiac Death Liver Transplant - An Analysis of the National Registry.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. TERRIER B , Carrat F, Geri G, Pol S, et al
     Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. FERNANDEZ-RUIZ V , Kawa M, Berasain C, Iniguez M, et al
     Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
147. WASMUTH HE , Trautwein C
     Prediction of fibrosis progression in hepatitis C infection: Are genetics ready for clinical use?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
148. REITER J , Perez-Vilaro G, Scheller N, Mina LB, et al
     Hepatitis C virus RNA recombination in cell culture.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. LANG T , Lo C, Skinner N, Locarnini S, et al
     The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. COANT N , Simon-Rudler M, Gustot T, Fasseu M, et al
     Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. MULLER T , Buch S, Berg T, Hampe J, et al
     Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
152. DULTZ G , Kronenberger B, Azizi A, Mihm U, et al
     Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. COMPARCOLA D , Nobili V, Balsano C, Alisi A, et al
     Effect of the treatment with polynsatured fatty acids on hcv- or diet-induced fatty liver.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
154. DEGOS F , Perez P, Asselineau J, Bedossa P, et al
     Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study).
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     January 2011
155. HALFON P , Locarnini S
     Hepatitis C virus Resistance to Protease Inhibitors.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. LOPEZ-LABRADOR FX , Berenguer M
     Genomic medicine reaches HCV-related liver transplantation: hopes and clinical and Public Health implications.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
157. SCHRAMM C , Lohse AW
     Role of mycophenolate mofetil in the treatment of autoimmune hepatitis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
158. PERON JM , Dalton H, Izopet J, Kamar N, et al
     Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin ?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
159. BERZSENYI MD , Woollard DJ, McLean CA, Preiss S, et al
     Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. ACHARYA SK
     Reply to the Letter to Editor entitled 'Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role of ribavirin?'
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
161. ZEREMSKI M , Hooker G, Shu MA, Winkelstein E, et al
     Induction of CXCR3- and CCR5-associated Chemokines during Acute Hepatitis C Virus Infection.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. WONG GL , Wong VW, Chan HL
     Is transient elastography inaccurate in chronic hepatitis B and non-alcoholic fatty liver disease?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
163. GAIA S
     Reply to comments on "Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis"
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
164. LENCI I , Tisone G, Di Paolo D, Marcuccilli F, et al
     Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver Transplanted for HBV-Related Cirrhosis at Low Risk of HBV Recurrence.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. VALLET-PICHARD A , Fontaine H, Mallet V, Pol S, et al
     Viral hepatitis in solid organ transplantation other than liver.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
166. HADZIYANNIS S
     Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
167. ZACHOU K , Gatselis N, Papadamou G, Rigopoulou EI, et al
     Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
168. HERKEL J , Carambia A
     Let it B in viral hepatitis?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
169. MICHE ML , Deng Q, Mancini-Bourgine M
     Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. MANNS M , Zeuzem S, Sood A, Lurie Y, et al
     Reduced Dose and Duration of Peginterferon alfa-2b and Weight-Based Ribavirin in Patients With Genotype 2 and 3 Chronic Hepatitis C.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. TORRESI J , Johnson D, Wedemeyer H
     Progress in the development of preventative and therapeutic vaccines for hepatitis C virus.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. NATTERMANN J
     NK cells in acute hepatitis C.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
173. SIKORSKA K , Stalke P, Bielawski KP
     Is there any Association between HCV Multiplication 0nd Iron Induced Liver Injury in Chronic Hepatitis C?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
174. FILLEBEEN C , Pantopoulos K
     Is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C?
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     
175. CAI T , Dufour JF, Muellhaupt B, Gerlach T, et al
     Viral Genotype-Specific Role of PNPLA3, PPARG, MTTP and IL28B in Hepatitis C Virus-Associated Steatosis.
     J Hepatol. 2011.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. FUSCO DN , Chung RT
     New Protease Inhibitors for HCV - Help is on the Way.
     J Hepatol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     December 2010
177. TAKANO T , Tsukiyama-Kohara K, Hayashi M, Hirata Y, et al
     Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. ALTER G , Jost S, Rihn S, Reyor LL, et al
     Reduced frequencies of NKp30+NKp46+, CD161+ and NKG2D+ NK cells in acute HCV infection may predict viral clearance.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. ASSELAH T
     NS5A inhibitors: a new breakthrough for the treatment of chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. LOHSE AW , Mieli-Vergani G
     Autoimmune Hepatitis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. GUEVARA M , Baccaro ME, Gomez-Anson B, Frisoni G, et al
     Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. ZHANG L , Jilg N, Shao RX, Lin W, et al
     IL28B inhibits Hepatitis C virus replication through the JAK-STAT pathway.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. LANGE CM , Moradpour D, Doehring A, Lehr HA, et al
     Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
184. OZE T , Hiramatsu N, Yakushijin T, Mochizuki K, et al
     Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
185. FORESTIER N , Larrey D, Guyader D, Marcellin P, et al
     Treatment of Chronic Hepatitis C Patients with the NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227) Leads to Robust Reductions in Viral RNA: A Phase 1b Multiple Ascending Dose Study.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
186. MARTIN NK , Vickerman P, Foster GR, Hutchinson SJ, et al
     Can antiviral therapy for Hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. ALISI A , Ghidinelli M, Zerbini A, Missale G, et al
     Hepatitis c virus and alcohol: same mitotic targets but different signaling pathways.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. SCHERZER TM , Hofer H, Staettermayer AF, Rutter K, et al
     Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
189. COSTENTIN CE , Roudot-Thoraval F, Zafrani ES, Medkour F, et al
     Association Of Caffeine Intake and Histological Features of Chronic Hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
190. LANGE CM , Bojunga J, Ramos-Lopez E, Wagner MV, et al
     Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
191. GIRARDI E , Scognamiglio P, Sciarrone MR, Loffredo MR, et al
     High HIV Prevalence in Male Patients With Acute Hepatitis A in the Rome metropolitan area, Italy 2002-2008.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
192. FERAY C
     Liver transplantation as a model to better understand the cell entry of hepatitis C virus.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
193. KHATTAB MA , Ferenci P, Hadziyannis SJ, Colombo M, et al
     Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
194. MANESIS EK , Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, et al
     Hepatitis B Surface Antigen:Relation to Hepatitis B Replication Parameters in HBeAg-Negative Chronic Hepatitis B.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
195. RAUTOU PE , Mansouri A, Lebrec D, Durand F, et al
     Autophagy in liver diseases.
     J Hepatol. 2010;53:1123-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
196. SHAWCROSS DL , Sharifi Y, Canavan JB, Yeoman AD, et al
     Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
197. GONZALEZ-CARMONA MA , Vogt A, Heinicke T, Quasdorff M, et al
     Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
198. ABE H , Imamura M, Hiraga N, Tsuge M, et al
     ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
199. SELZNER N , Guindi M, Renner EL, Berenguer M, et al
     Immune-mediated complications of the graft in interferon-treated Hepatitis C positive Liver transplant recipients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
200. BREMER CM , Sominskaya I, Skrastina D, Pumpens P, et al
     N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
201. DRUMRIGHT LN , Hagan H, Thomas DL, Latka MH, et al
     Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
202. TREPO E , Potthoff A, Pradat P, Bakshi R, et al
     Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
203. TABATABAEI SV , Alavian SM, Keshvari M, Behnava B, et al
     Low Dose Ribavirin for Treatment of HCV Infected Thalassemia Major Patients; New Indications for Combination Therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
204. FRIED MW , Hadziyannis SJ, Shiffman ML, Messinger D, et al
     Rapid Virological Response Is the Most Important Predictor of Sustained Virological Response Across Genotypes in Patients with Chronic Hepatitis C Virus Infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
205. GREBELY J , Matthews GV, Hellard M, Shaw D, et al
     Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
206. OLIVIERO B , Cerino A, Varchetta S, Paudice E, et al
     Enhanced B Cell Differentiation and Reduced Proliferative Capacity in Chronic Hepatitis C and Chronic Hepatitis B Virus Infections.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
207. GEHRING AJ , Xue SA, Ho ZZ, Teoh D, et al
     Engineering Virus-specific T cells that Target HBV Infected Hepatocytes and Hepatocellular Carcinoma Cell Lines.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
208. PIANA G , Trinquart L, Meskine N, Barrau V, et al
     New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
209. FUJIMOTO Y , Ochi H, Maekawa T, Abe H, et al
     A single nucleotide polymorphism in activated cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
210. BOSE PD , Das BC, Kumar A, Gondal R, et al
     High viral load and deregulation of Progesterone receptor signaling pathway: Association with Hepatitis E related poor pregnancy outcome.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
211. KUANG DM , Zhao Q, Wu Y, Peng C, et al
     Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
212. ZEISEL MB , Fofana I, Fafi-Kremer S, Baumert TF, et al
     Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
213. MANNS MP , Bourliere M, Benhamou Y, Pol S, et al
     Potency, safety and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
214. LAGGING M , Alsio S, Hellstrand K, Norkrans G, et al
     Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
215. BUSTER EH , Janssen HL
     The importance of HBV genotype in HBeAg-positive chronic hepatitis B patients in whom sustained response is pursued.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
216. REIJNDERS JG , Rijckborst V, Sonneveld MJ, Scherbeijn SM, et al
     Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
217. NOVO E , Busletta C, di Bonzo LV, Povero D, et al
     Intracellular Reactive Oxygen Species Are Required For Directional Migration Of Resident And Bone Marrow-Derived Hepatic Pro-Fibrogenic Cells.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
218. GAO P , Chak-Lui Wong C, Kwok-Kwan Tung E, Man-Fong Lee J, et al
     Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
219. UM TH , Kim H, Oh BK, Kim MS, et al
     Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
220. LOHSE AW , Gil H
     Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
221. OHARA E , Hiraga N, Imamura M, Iwao E, et al
     Elimination of Hepatitis C Virus by Short Term NS3-4A and NS5B Inhibitor Combination Therapy in Human Hepatocyte Chimeric Mice.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
222. DE JONG YP , Rice CM, Ploss A
     Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
223. BARTH H
     Insights into the role of interferon lambda in hepatitis C virus infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
224. LANGHANS B , Kupfer B, Braunschweiger I, Arndt S, et al
     Interferon-lambda serum levels in hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
225. WALTER SR , Thein HH, Amin J, Gidding HF, et al
     Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
226. SHOUVAL D
     Potential short-term mortality risk in patients undergoing entecavir treatment for spontaneous exacerbation of chronic hepatitis B: Fact or bias?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
227. FUNG J , Seto WK, Lai CL, Yuen J, et al
     Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
228. BERG T , Biermer M, Neumann U
     Silibinin in hepatitis C related liver transplantation.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
229. BEINHARDT S , Rasoul-Rockenschaub S, Scherzer TM, Ferenci P, et al
     Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
230. MCCAUGHAN GW , Bowen DG
     Pathogenesis of cholestatic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
231. LEE M , Keeffe EB
     Study of adherence comes to the treatment of chronic hepatitis B.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
232. FRAQUELLI M , Rigamonti C, Casazza G, Donato MF, et al
     Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
233. JANG JY , Shao RX, Lin W, Weinberg E, et al
     HIV infection increases HCV-induced hepatocyte apoptosis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
234. RIEZU-BOJ JI , Larrea E, Aldabe R, Guembe L, et al
     Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
235. SHOUVAL D
     What is the significance of hepatitis E as a public health threat in the industrialized countries? Hepatitis E virus infection in Italy.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
236. LAMBERT MP , Paliwal A, Vaissiere T, Chemin I, et al
     Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
237. MIYOSHI H , Moriya K, Tsutsumi T, Shinzawa S, et al
     Pathogenesis of lipid metabolism disorder in hepatitis C: Polyunsaturated fatty acids counteract lipid alterations induced by the core protein.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
238. SARRAZIN C , Susser S, Doehring A, Lange CM, et al
     Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
239. KAWAOKA T , Hayes CN, Ohishi W, Ochi H, et al
     Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
240. KUROSAKI M , Tanaka Y, Nishida N, Sakamoto N, et al
     Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
241. SANDAHL TD , Jepsen P, Thomsen KL, Vilstrup H, et al
     Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: A nationwide population based cohort study.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
242. FABRIS C , Falleti E, Cussigh A, Bitetto D, et al
     IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
243. BOBERG KM , Chapman RW, Hirschfield GM, Lohse AW, et al
     Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
244. LOHSE AW
     Recognizing autoimmune hepatitis: Scores help, but no more.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
245. POYNARD T , Munteanu M, Colombo M, Bruix J, et al
     FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC(3) program.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
246. SCHULTE I , Hitziger T, Giugliano S, Timm J, et al
     Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
247. QIU D , Wang Q, Wang H, Xie Q, et al
     Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
248. ACHARYA SK , Panda SK
     Hepatitis E: Water, water everywhere - Now a Global Disease.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
249. WONG VW , Wong GL, Yiu KK, Chim AM, et al
     Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
250. HUANG JF , Yu ML, Huang CF, Chiu CF, et al
     The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
251. XIANG WQ , Feng WF, Ke W, Sun Z, et al
     Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
252. TJWA ET , van Oord GW, Hegmans JP, Janssen HL, et al
     Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
253. DIMOVA RB , Talal AH
     Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa.
     J Hepatol. 2010;53:418-20.
     PubMed     Text format     Related articles   
     
     
     
     August 2010
254. GARCIA-MONZON C , Lo Iacono O, Mayoral R, Gonzalez-Rodriguez A, et al
     Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
255. WU S , Imazeki F, Kurbanov F, Fukai K, et al
     Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
256. MUELLER S
     Increased iron in HCV infection: Collateral damage or antiviral defense?
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
257. GAIA S , Carenzi S, Barilli AL, Bugianesi E, et al
     Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
258. SYDER AJ , Lee H, Zeisel MB, Grove J, et al
     Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
259. VACHON ML , Factor SH, Branch AD, Fiel MI, et al
     Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-alpha-2a and ribavirin in HIV/HCV co-infected patients.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
260. CHOTIYAPUTTA W , Peterson C, Ditah FA, Goodwin D, et al
     Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
261. ROMANO L , Paladini S, Tagliacarne C, Canuti M, et al
     Hepatitis E in Italy: A long-term prospective study.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
262. DEGOS F , Perez P, Roche B, Mahmoudi A, et al
     Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study).
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
263. SHOUVAL D
     Focus.
     J Hepatol. 2010;53:219-20.
     PubMed     Text format     Related articles   
     
     
     
     
264. RATZIU V
     Serum fibrosis markers: death by validation or a leap of faith?
     J Hepatol. 2010;53:222-4.
     PubMed     Text format     Related articles   
     
     
     
     
265. TAK WY , Park SY, Cho CM, Jung MK, et al
     Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy.
     J Hepatol. 2010;53:261-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
266. GOETZ M , Deris I, Vieth M, Murr E, et al
     Near-infrared confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with increased imaging plane depth.
     J Hepatol. 2010;53:84-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
267. ROBINET E , Baumert TF
     Host and viral determinants for engraftment of virus permissive human hepatocytes into chimeric immunodeficient mice.
     J Hepatol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     March 2010
268. WATT KD , Charlton MR
     Metabolic syndrome and liver transplantation: A review and guide to management.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
269. DHILLON N , Walsh L, Kruger B, Ward SC, et al
     A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation.
     J Hepatol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
270. SAMUEL D
     Focus.
     J Hepatol. 2010;52:3-4.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: